Veeva Systems Inc. (NYSE: VEEV) saw its stock surge 6.85% in after-hours trading on Wednesday, driven by the company's impressive fourth-quarter results and optimistic guidance for the upcoming fiscal year. The cloud-based software provider for the life sciences industry continues to capitalize on robust demand for its industry-specific solutions.

For the fourth quarter of fiscal year 2025, Veeva reported total revenues of $720.9 million, up 14.3% year-over-year, exceeding analyst estimates of $699.4 million. Adjusted earnings per share (EPS) came in at $1.74, surpassing the consensus forecast of $1.58 by a significant margin. Subscription services revenues, a key growth driver, increased by 17% year-over-year to $608.6 million.

Looking ahead, Veeva provided an optimistic outlook, reflecting its confidence in its growth trajectory. For the first quarter of fiscal 2026, the company expects total revenues between $726 million and $729 million, with non-GAAP EPS in the range of $1.74 to $1.75. For the full fiscal year 2026, Veeva forecasts total revenues between $3.04 billion and $3.055 billion, and non-GAAP EPS of approximately $7.32.

Veeva's robust performance can be attributed to its continued innovation and expansion of its industry-specific product portfolio. During the quarter, the company launched Veeva CRM Pulse, a data subscription service aimed at enhancing healthcare provider (HCP) engagement metrics for life sciences companies. Additionally, Veeva reported strong adoption of its Vault CRM Suite, with over 50 customers now live on the advanced CRM solution, positioning the company as a frontrunner in the industry.